Publicacions en què col·labora amb Fernando Pardo Sánchez (18)

2023

  1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

2022

  1. Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes

    Langenbeck's Archives of Surgery, Vol. 407, Núm. 3, pp. 1099-1111

2017

  1. Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation

    Annals of Transplantation, Vol. 22, pp. 141-147

  2. Totally laparoscopic right hepatectomy for living donor liver transplantation: Analysis of a preliminary experience on 5 consecutive cases

    Transplantation, Vol. 101, Núm. 3, pp. 548-554

2015

  1. Immune monitoring of immunosuppression withdrawal of liver transplant recipients

    Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116

2014

  1. Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?

    Transplantation Proceedings

  2. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension

    HPB, Vol. 16, Núm. 3, pp. 243-249

2013

  1. Lung cancer screening with low-radiation dose computed tomography after liver transplantation

    Annals of Transplantation, Vol. 18, Núm. 1, pp. 587-592

  2. Reply to: Downstaging to liver resection by radioembolization: A difficult to reach strategy?

    European Journal of Surgical Oncology

  3. Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

    Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944

2012

  1. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation

    Transplantation Proceedings

  2. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

    European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601

  3. Subsequent nonmelanoma skin cancer after liver transplantation

    Transplantation Proceedings

2011

  1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

  2. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

    Liver Transplantation, Vol. 17, Núm. 4, pp. 402-408

2009

  1. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals

    Liver Transplantation, Vol. 15, Núm. 1, pp. 111-114

  2. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

    Clinical Transplantation, Vol. 23, Núm. 4, pp. 532-536

2008

  1. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

    Liver Transplantation, Vol. 14, Núm. 3, pp. 272-278